A 22-year-old male with extensive steroid-dependent/azathioprine-refractory ulcerative colitis and preexistent severe refractory acne pustolosa (AP) was successfully treated with adalimumab for both conditions. Severe AP could be considered a further indication, instead of a relative restriction, to anti-TNFα in steroid-dependent IBD patients needing therapy with this class of drugs.
Keywords: Acne pustolosa; adalimumab; inflammatory bowel diseases; infliximab; tumor necrosis factor alpha; ulcerative colitis.